Advanced Centre for Treatment Research & Education in Cancer

Science Sparks @ ACTREC
24^th August 2026	Vol. No. 15 ; Issue No.749

Publications

1. Balaji K, Ghogale SG, Deshpande N, Patil J, Girase K, Poojary S, Chatterjee G, Rajpal S, Patkar N, Epari S, Shet T, Gujral S, Subramanian PG, Tembhare PR (2026). Utility of multiparametric flow cytometry in the diagnosis and staging of Classic Hodgkin lymphoma-Experience in real-world practice. Cytometry Part B: Clinical Cytometry.

2. Roy R, Ria T, Das K, Patial V, Das G, Sk UH (2026). A Rationally Engineered Norfloxacin-Phenoxazine Hybrid as a Dual-Function Anticancer Agent: DNA Intercalation Synergizes with Topoisomerase II Inhibition against Murine Breast Tumor. ACS Medicinal Chemistry Letters. 17(8):1678-1690.

Site of the Week

The Bharat Cancer Genome Atlas (BCGA) is a pioneering compendium of genetic variants representing the unique genomic landscape of cancers in India. By bridging the gap in genomic data, BCGA empowers healthcare systems and researchers to create targeted solutions that improve outcomes for millions of cancer patients.

Interesting Reads

Engelhardt B, Platten M(2026). Brain barriers at the crossroads of glioma immune surveillance and immunotherapy response. Nature Reviews Cancer.

Video of the Week

Stimuli-Responsive Platinum (IV) Prodrug- Photodynamic Nanomedicines

Upcoming Events

Workshop on Cancer Epidemiology and Public Health

September 3-5, 2026,

At ACTREC, Tata Memorial Centre, Kharghar, Navi Mumbai

Workshop On Cell Line Generation & CME on Tumor Microenvironment

October 8-10, 2026

At ACTREC, Tata Memorial Centre, Kharghar, Navi Mumbai

Cytogenomic Microarray Workshop

October 26-29, 2026

At ACTREC, Tata Memorial Centre, Kharghar, Navi Mumbai.

Do You Know?

In 1995, Tretinoin ( Vesanoid), a drug related to vitamin A was found to cause remission in patients with acute promyelocytic leukemia (APL)

Cancer News

Younger adults with lung cancer more likely to have targetable genetic changes, study finds

EurekAlert, 20/08/2026

The study supports broader use of comprehensive genomic profiling, especially for younger adults diagnosed with non-small cell lung cancer. Testing can help doctors identify whether a tumor has a genetic driver that may respond to a targeted therapy...

Scientists turn probiotic bacteria into tiny drug factories for pancreatic cancer.

Sciencedaily, 19/08/2026

Engineered probiotic bacteria were able to infiltrate pancreatic tumors, stimulate cancer-fighting immune cells, and slow tumor growth in animal studies. Even more strikingly, the treatment worked better when combined with chemotherapy, radiation, or immunotherapy...

Nanoplatelets, a potential drug delivery vehicle for targeted cancer therapy.

News-Medical, 18/08/2026

Targeted radionuclide therapy (TRT) is an important area of research for developing drugs to treat cancer. TRT attaches radioisotopes to molecules that target cancer cells...

2026 Advanced Centre for Treatment, Research and Education in Cancer (ACTREC)